Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Single-arm Study to Assess the Safety, Efficacy, Discontinuation Rate and Pharmacokinetics of the Low-dose Levonorgestrel Intrauterine Contraceptive System (LCS12) in Post-menarcheal Female Adolescents Under 18 Years of Age for 1 Year, and an Optional 2-year Extension Phase

NCT01434160 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01434160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01434160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Single-arm Study to Assess the Safety, Efficacy, Discontinuation Rate and Pharmacokinetics of the Low-dose Levonorgestrel Intrauterine Contraceptive System (LCS12) in Post-menarcheal Female Adolescents Under 18 Years of Age for 1 Year, and an Optional 2-year Extension Phase
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2011
Completion date
May 31, 2015
Enrollment
304 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

contraception